Skip to main content

Table 1 Clinical characteristics of eyes with PIOL

From: Changes of choroidal structure after treatment for primary intraocular lymphoma: retrospective, observational case series

Case No.

Age Years/ Gender

Side

PCNSL prior to PIOL

Cytological diagnosis

Intraocular cytokine level

Ocular findings

Number of IVMTX

BCVA before IVMTX

BCVA after IVMTX

IL-10 (pg/mL)

IL-6 (pg/mL)

Ratio of IL-10/IL-6

1

59/M

OD

+

N/A

825

45

18.3

Iritis,OCV

9

1.2

1.5

OS

N/A

5080

89.5

56.8

Iritis,OCV

9

0.6

0.9

2

67/F

OD

-

Class III

1870

1370

1.4

OCV, retinitis

8

0.9

0.9

3

77/M

OS

-

Class I

696

35.6

19.6

OCV, retinal infiltration (macula, periphery)

6

1.0

0.9

4

57/M

OD

-

Died before vitrectomy

225

22.4

10.0

OCV, retinal infiltration (posterior pole)

Died before IVMTX

0.4

N/A

OS

Class V

3150

102

30.9

OCV, retinal infiltration (macula)

9

0.9

1.2

  1. BCVA best-corrected visual acuity, IL interleukin, IVMTX intravitreal injection of methtorexate, N/A not available, OCV vitreous opacity, OD right eye, OS left eye, PCNSL primary central nervous system lymphoma, PIOL primary intraocular lymphoma